Increased susceptibility to cardiovascular effects of dihydrocapcaicin in resuscitated rats. Cardiovascular effects of dihydrocapsaicin

BMC Cardiovascular Disorders

Volumn 10, Issue , 2010, Pages

  Fosgerau, Keld ^a   Ristagno, Giuseppe ^b   Jayatissa, Magdalena ^a   Axelsen, Mads ^a   Gotfredsen, Jacob W ^a   Weber, Uno J ^a   Køber, Lars ^a   Torp Pedersen, Christian ^a   Videbaek, Charlotte ^a  

^a Neurokey AS   (Denmark)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DIHYDROCAPSAICIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; VANILLOID RECEPTOR AGONIST; CAPSAICIN; DRUG DERIVATIVE; TRANSIENT RECEPTOR POTENTIAL CHANNEL; VANILLOID RECEPTOR; VANILLOID RECEPTOR SUBTYPE 1;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA EJECTION TIME; ARTICLE; ATRIOVENTRICULAR BLOCK; BEZOLD JARISCH REFLEX; BLOOD TEMPERATURE; BODY TEMPERATURE; BRADYCARDIA; BREATHING RATE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR REFLEX; CLINICAL OBSERVATION; COMPLETE HEART BLOCK; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; EXTERNAL EAR; HEART ARREST; HEART ARRHYTHMIA; HEART RATE; HYPOTENSION; INDUCED HYPOTHERMIA; INFUSION RATE; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; MOTOR ACTIVITY; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECUMBENCY; RED PINNAE; REFLEX; RESTLESSNESS; RESUSCITATION; SPRAGUE DAWLEY RAT; TACHYCARDIA; THORAX MUSCLE TREMOR; VOCALIZATION; ANIMAL; CARDIOVERSION; DISEASE MODEL; DRUG POTENTIATION; FORWARD HEART FAILURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY;

ANIMALS; ARRHYTHMIAS, CARDIAC; CAPSAICIN; CARDIAC OUTPUT, LOW; DISEASE MODELS, ANIMAL; ELECTRIC COUNTERSHOCK; HEART ARREST; HUMANS; INFUSIONS, INTRAVENOUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RESUSCITATION; TRANSIENT RECEPTOR POTENTIAL CHANNELS; TRPV CATION CHANNELS;

EID: 77956881598     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-10-39     Document Type: Article

References (38)

1. Gudermann T, Flockerzi V. TRP channels as new pharmacological targets. Naunyn Schmiedebergs Arch Pharmacol 2005, 371(4):241-244. 10.1007/s00210-005-1029-7, 15756597.
2. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389(6653):816-824. 10.1038/39807, 9349813.
3. Vriens J, Nilius B, Vennekens R. Herbal Compounds and Toxins Modulating TRP Channels. Curr Neuropharmacol 2008, 6(1):79-96. 10.2174/157015908783769644, 2645550, 19305789.
4. Szallasi A, Cortright DN, Blum CA, Eid SR. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 2007, 6(5):357-372. 10.1038/nrd2280, 17464295.
5. Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 1999, 51(2):159-212.
6. Toth A, Boczan J, Kedei N, Lizanecz E, Bagi Z, Papp Z, Edes I, Csiba L, Blumberg PM. Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res Mol Brain Res 2005, 135(1-2):162-168. 10.1016/j.molbrainres.2004.12.003, 15857679.
7. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991, 43(2):143-201.
8. Caterina MJ. Transient receptor potential ion channels as participants in thermosensation and thermoregulation. Am J Physiol Regul Integr Comp Physiol 2007, 292(1):R64-76.
9. Romanovsky AA. Thermoregulation: some concepts have changed. Functional architecture of the thermoregulatory system. Am J Physiol Regul Integr Comp Physiol 2007, 292(1):R37-46.
10. Gunthorpe MJ, Szallasi A. Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms. Curr Pharm Des 2008, 14(1):32-41. 10.2174/138161208783330754, 18220816.
11. Starowicz K, Cristino L, Di Marzo V. TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications. Curr Pharm Des 2008, 14(1):42-54. 10.2174/138161208783330790, 18220817.
12. Veronesi B, Oortgiesen M. The TRPV1 receptor: target of toxicants and therapeutics. Toxicol Sci 2006, 89(1):1-3. 10.1093/toxsci/kfj034, 16404782.
13. Lin YS, Lin RL, Bien MY, Ho CY, Kou YR. Sensitization of capsaicin-sensitive lung vagal afferents by anandamide in rats: role of transient receptor potential vanilloid 1 receptors. J Appl Physiol 2009, 106(4):1142-1152. 10.1152/japplphysiol.91229.2008, 19131477.
14. Yiangou Y, Facer P, Dyer NH, Chan CL, Knowles C, Williams NS, Anand P. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 2001, 357(9265):1338-1339. 10.1016/S0140-6736(00)04503-7, 11343743.
15. Coleridge JC, Coleridge HM. Afferent vagal C fibre innervation of the lungs and airways and its functional significance. Rev Physiol Biochem Pharmacol 1984, 99:1-110. full_text, 6695127.
16. Toda N, Usui H, Nishino N, Fujiwara M. Cardiovascular effects of capsaicin in dogs and rabbits. J Pharmacol Exp Ther 1972, 181(3):512-521.
17. Chanda S, Mould A, Esmail A, Bley K. Toxicity studies with pure trans-capsaicin delivered to dogs via intravenous administration. Regul Toxicol Pharmacol 2005, 43(1):66-75. 10.1016/j.yrtph.2005.06.003, 16051405.
18. Hancock JC, Hoover DB. Capsaicin-evoked bradycardia in anesthetized guinea pigs is mediated by endogenous tachykinins. Regul Pept 2008, 147(1-3):19-24. 10.1016/j.regpep.2007.12.001, 18207255.
19. Varga K, Lake KD, Huangfu D, Guyenet PG, Kunos G. Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 1996, 28(4):682-686.
20. Pacher P, Batkai S, Kunos G. Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice. J Physiol 2004, 558(Pt 2):647-657. 10.1113/jphysiol.2004.064824, 1664980, 15121805.
21. Miller MS, Brendel K, Buck SH, Burks TF. Dihydrocapsaicin-induced hypothermia and substance P depletion. Eur J Pharmacol 1982, 83(3-4):289-292. 10.1016/0014-2999(82)90263-1, 6184240.
22. Chiao H, Caldwell RW. Local cardiac effects of substance P: roles of acetylcholine and noradrenaline. Br J Pharmacol 1995, 114(2):283-288. 1510236, 7533612.
23. Hoover DB. Effects of substance P on rate and perfusion pressure in the isolated guinea pig heart. J Pharmacol Exp Ther 1990, 252(1):179-184.
24. Hoover DB, Hancock JC. Distribution of substance P binding sites in guinea-pig heart and pharmacological effects of substance P. J Auton Nerv Syst 1988, 23(3):189-197. 10.1016/0165-1838(88)90093-8, 2461407.
25. Tompkins JD, Hoover DB, Hancock JC. Substance P evokes bradycardia by stimulation of postganglionic cholinergic neurons. Peptides 1999, 20(5):623-628. 10.1016/S0196-9781(99)00016-9, 10465515.
26. Lundberg JM, Franco-Cereceda A, Hua X, Hokfelt T, Fischer JA. Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol 1985, 108(3):315-319. 10.1016/0014-2999(85)90456-X, 2580718.
27. Lundberg JM, Franco-Cereceda A, Lacroix JS, Pernow J. Release of vasoactive peptides from autonomic and sensory nerves. Blood Vessels 1991, 28(1-3):27-34.
28. Huang L, Weil MH, Sun S, Cammarata G, Cao L, Tang W. Levosimendan improves postresuscitation outcomes in a rat model of CPR. J Lab Clin Med 2005, 146(5):256-261. 10.1016/j.lab.2005.07.005, 16242524.
29. Fang X, Tang W, Sun S, Huang L, Chang YT, Huang Z, Weil MH. Cardiopulmonary resuscitation in a rat model of chronic myocardial ischemia. J Appl Physiol 2006, 101(4):1091-1096. 10.1152/japplphysiol.01487.2005, 16794017.
30. von Planta I, Weil MH, von Planta M, Bisera J, Bruno S, Gazmuri RJ, Rackow EC. Cardiopulmonary resuscitation in the rat. J Appl Physiol 1988, 65(6):2641-2647.
31. Saito A, Yamamoto M. Acute oral toxicity of capsaicin in mice and rats. J Toxicol Sci 1996, 21(3):195-200.
32. Harron DW, Kobinger W. Facilitation of the Bezold-Jarisch reflex by central stimulation of alpha 2 adrenoceptors in dogs. Naunyn Schmiedebergs Arch Pharmacol 1984, 325(3):193-197. 10.1007/BF00495942, 6145098.
33. Aviado DM, Guevara Aviado D. The Bezold-Jarisch reflex. A historical perspective of cardiopulmonary reflexes. Ann N Y Acad Sci 2001, 940:48-58. 10.1111/j.1749-6632.2001.tb03666.x, 11458703.
34. Tang W, Weil MH, Sun S, Gazmuri RJ, Bisera J. Progressive myocardial dysfunction after cardiac resuscitation. Crit Care Med 1993, 21(7):1046-1050. 10.1097/00003246-199307000-00022, 8319463.
35. Cerchiari EL, Safar P, Klein E, Cantadore R, Pinsky M. Cardiovascular function and neurologic outcome after cardiac arrest in dogs. The cardiovascular post-resuscitation syndrome. Resuscitation 1993, 25(1):9-33. 10.1016/0300-9572(93)90003-9, 8446790.
36. Yan GX, Kleber AG. Changes in extracellular and intracellular pH in ischemic rabbit papillary muscle. Circ Res 1992, 71(2):460-470.
37. Sun S, Weil MH, Tang W, Fukui M. Effects of buffer agents on postresuscitation myocardial dysfunction. Crit Care Med 1996, 24(12):2035-2041. 10.1097/00003246-199612000-00017, 8968273.
38. McNamara FN, Randall A, Gunthorpe MJ. Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1). Br J Pharmacol 2005, 144(6):781-790. 10.1038/sj.bjp.0706040, 1576058, 15685214.